Medicare Drug Price Negotiations: Major Savings for Seniors on Cancer and Chronic Disease Medicat...

By HEOR Staff Writer

December 1, 2025

Medicare drug price negotiations are transforming access to affordable healthcare for seniors, and if you're wondering how these negotiations will lower costs for high-expense cancer and chronic disease treatments, the answer is clear. Starting January 1, 2027, the Centers for Medicare & Medi...
Enhancing Efficiency in FAST-EU Clinical Trials: A New Era for Biomedical Research

By João L. Carapinha

Advancing EU Clinical Trial Efficiency Through FAST-EU Trials The FAST-EU clinical trials initiative, launched by a coalition of National Competent Authorities (NCAs) and Ethics Committees across the European Union/Europ...
Advancements in Continuous Glucose Monitoring for Type 2 Diabetes Management

By HEOR Staff Writer

November 27, 2025

Advancements in CGM for Type 2 Diabetes Management A recent JAMA Insights article, explores the integration of continuous glucose monitoring as a complementary tool to traditional hemoglobin A1c (HbA1c) an...
GLP-1RAs Psychiatric Care: Transforming Metabolic Management for Psychotropic Patients

By HEOR Staff Writer

Emerging Role of GLP-1 Receptor Agonists In psychiatric care, GLP-1RAs offer a promising approach for managing weight gain induced by psychotropic medications, as detailed in this
NICE Endorses Obecabtagene Autoleucel Therapy for Adult Relapsed B-Cell Leukaemia

By João L. Carapinha

November 25, 2025

NICE Backs Obecabtagene Autoleucel The National Institute for Health and Care Excellence (NICE) recommended obecabtagene autoleucel therapy, a UK-developed chimeric antigen receptor (CAR) T-cell trea...
Accelerating Access to Latin America Innovative Therapies Through Collaboration and Innovation

By HEOR Staff Writer

Accelerating Access to Latin America Innovative Therapies In this update we outline a strategic vision for transforming Latin America's healthcare systems through innovation, collaboration, and equitable access, with a stron...
View All News
Search By Category

Syenza's Top Picks

Oral Semaglutide Benefits: EMA Approves First Oral GLP-1 RA with Cardiovascular Perks

Empowering Innovation: Clinical Trials Reform Strategies by EMA for 2025

Biosimilars Market Trends 2025: Understanding Erosion and Growth

Impact of Generic Liraglutide Launch on Weight Management and Health Economics

NICE Kidney Cancer Guideline: Enhancing Biopsy Use to Minimize Unnecessary Surgery

New Federal Actions to Combat Misleading Prescription Drug Ads in 2025

Ending Unproven Fertility Treatments: NICE Calls for Evidence-Based Care in Clinics

Latest

Medicare Drug Price Negotiations: Major Savings for Seniors on Cancer and Chronic Disease Medicat...

By HEOR Staff Writer

December 1, 2025

Medicare drug price negotiations are transforming access to affordable healthcare for seniors, and if you're wondering how these negotiations will lower costs for high-expense cancer and chronic disease treatments, the answer is clear. Starting January 1, 2027, the Centers for Medicare & Medi...

Latest

Enhancing Efficiency in FAST-EU Clinical Trials: A New Era for Biomedical Research

By João L. Carapinha

Advancing EU Clinical Trial Efficiency Through FAST-EU Trials The FAST-EU clinical trials initiative, launched by a coalition of National Competent Authorities (NCAs) and Ethics Committees across the European Union/Europ...

Latest

Advancements in Continuous Glucose Monitoring for Type 2 Diabetes Management

By HEOR Staff Writer

November 27, 2025

Advancements in CGM for Type 2 Diabetes Management A recent JAMA Insights article, explores the integration of continuous glucose monitoring as a complementary tool to traditional hemoglobin A1c (HbA1c) an...

Latest

GLP-1RAs Psychiatric Care: Transforming Metabolic Management for Psychotropic Patients

By HEOR Staff Writer

Emerging Role of GLP-1 Receptor Agonists In psychiatric care, GLP-1RAs offer a promising approach for managing weight gain induced by psychotropic medications, as detailed in this

Global Updates

Accelerating Access to Latin America Innovative Therapies Through Collaboration and Innovation

By HEOR Staff Writer

November 25, 2025

Accelerating Access to Latin America Innovative Therapies In this update we outline a strategic vision for transforming Latin America's healthcare systems through innovation, collaboration, and equitable access, with a stron...

Global Updates

Rethinking HEOR Market Access Integration: A Call for Early Engagement Before Phase 3

By João L. Carapinha

November 24, 2025

Early HEOR Market Access Integration In this brief interview on ISPOR, Indranil Bagchi asserts that HEOR market access integration must occur earlier in drug development—ideally before Ph...

Global Updates

Patient-Reported Outcomes Trends in Clinical Trials: Insights from 2008-2023

By HEOR Staff Writer

Patient-reported outcomes trends show a clear surge in clinical trials from 2008 to 2023, where usage has doubled in interventional studies, while tools like EQ-5D lead as the top generic instrument, with PROMIS seeing e...

Global Updates

Addressing AI Polyp Detection Gaps: A Roadmap for Evidence Generation and NHS Integration

By HEOR Staff Writer

Addressing Evidence Gaps in AI Polyp Detection AI Polyp Detection Gaps persist in colorectal cancer screening, as highlighted by the National Institute for He...

Europe

View All
Enhancing Efficiency in FAST-EU Clinical Trials: A New Era for Biomedical Research

By João L. Carapinha

December 1, 2025

Advancing EU Clinical Trial Efficiency Through FAST-EU Trials The FAST-EU clinical trials initiative, launched by a coalition of National Competent Authorities (NCAs) and Ethics Committees across the European Union/Europ...
NICE Endorses Obecabtagene Autoleucel Therapy for Adult Relapsed B-Cell Leukaemia

By João L. Carapinha

November 25, 2025

NICE Backs Obecabtagene Autoleucel The National Institute for Health and Care Excellence (NICE) recommended obecabtagene autoleucel therapy, a UK-developed chimeric antigen receptor (CAR) T-cell trea...
Rethinking HEOR Market Access Integration: A Call for Early Engagement Before Phase 3

By João L. Carapinha

November 24, 2025

Early HEOR Market Access Integration In this brief interview on ISPOR, Indranil Bagchi asserts that HEOR market access integration must occur earlier in drug development—ideally before Ph...
Addressing AI Polyp Detection Gaps: A Roadmap for Evidence Generation and NHS Integration

By HEOR Staff Writer

Addressing Evidence Gaps in AI Polyp Detection AI Polyp Detection Gaps persist in colorectal cancer screening, as highlighted by the National Institute for He...

North America

View All
Medicare Drug Price Negotiations: Major Savings for Seniors on Cancer and Chronic Disease Medicat...

By HEOR Staff Writer

December 1, 2025

Medicare drug price negotiations are transforming access to affordable healthcare for seniors, and if you're wondering how these negotiations will lower costs for high-expense cancer and chronic disease treatments, the answer is clear. Starting January 1, 2027, the Centers for Medicare & Medi...
Advancements in Continuous Glucose Monitoring for Type 2 Diabetes Management

By HEOR Staff Writer

November 27, 2025

Advancements in CGM for Type 2 Diabetes Management A recent JAMA Insights article, explores the integration of continuous glucose monitoring as a complementary tool to traditional hemoglobin A1c (HbA1c) an...
GLP-1RAs Psychiatric Care: Transforming Metabolic Management for Psychotropic Patients

By HEOR Staff Writer

Emerging Role of GLP-1 Receptor Agonists In psychiatric care, GLP-1RAs offer a promising approach for managing weight gain induced by psychotropic medications, as detailed in this
Rethinking HEOR Market Access Integration: A Call for Early Engagement Before Phase 3

By João L. Carapinha

November 24, 2025

Early HEOR Market Access Integration In this brief interview on ISPOR, Indranil Bagchi asserts that HEOR market access integration must occur earlier in drug development—ideally before Ph...

Sub-Saharan Africa

View All
AI in South African Healthcare: Professionals’ Confidence in Reducing Admissions and Enhanc...

By HEOR Staff Writer

November 5, 2025

AI Optimism in South Africa's Healthcare Landscape AI in South African Healthcare is gaining momentum, as evidenced by the Philips Future Health Index (FHI...
Shifting Toward Sustainable Reimbursement Models in South Africa’s Healthcare Sector

By João L. Carapinha

November 4, 2025

Escaping Fee-for-Service: Pathways to Sustainable Reimbursement Models The Council for Medical Schemes (CMS) Annual Report 2024/25 undersc...
Medical Schemes Affordability Crisis: Insights from the CMS Annual Report 2024/25

By João L. Carapinha

October 31, 2025

The CMS Annual Report 2024/25 highlights significant medical schemes affordability challenges in South Africa, where relevant healthcare expenditure per beneficiary surged by 8.70% year-on-year, far outpacing both contribution growth and general inflation. Solvency ratios have declined for three ...
Barriers to African Pharmaceutical Growth: Navigating Regulatory and Procurement Challenges

By João L. Carapinha

October 30, 2025

African Pharmaceutical Growth African Pharmaceutical Growth remains stifled by significant barriers, as highlighted in a recent plenary address at the Conference on Public Health in Africa (CPHIA) 2025 (reported by Health Policy Watch). Dr. Stavros Nicolaou, group senior executive for s...